GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (FRA:PSH) » Definitions » Additional Paid-In Capital

Sernova (FRA:PSH) Additional Paid-In Capital

: €14.20 Mil(As of Jan. 2024)
View and export this data going back to 2014. Start your Free Trial

Sernova's quarterly additional paid-in capital increased from Jul. 2023 (€12.83 Mil) to Oct. 2023 (€13.60 Mil) and increased from Oct. 2023 (€13.60 Mil) to Jan. 2024 (€14.20 Mil).

Sernova's annual additional paid-in capital increased from Oct. 2021 (€3.55 Mil) to Oct. 2022 (€9.26 Mil) and increased from Oct. 2022 (€9.26 Mil) to Oct. 2023 (€13.60 Mil).

Sernova Additional Paid-In Capital Historical Data

The historical data trend for Sernova's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Additional Paid-In Capital
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.38 3.69 3.55 9.26 13.60

Sernova Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Additional Paid-In Capital Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.29 11.95 12.83 13.60 14.20

Sernova Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Sernova Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sernova's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova (FRA:PSH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (FRA:PSH) » Definitions » Additional Paid-In Capital
Comparable Companies
TSX:EPRX TSXV:ARCH TSXV:NGEN TSX:MDNA TSX:ONC TSX:TH XCNQ:ACOG XCNQ:METX XCNQ:DTC TSX:BCT OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX
Traded in Other Exchanges
SEOVF:USA PSH:Germany SVA:Canada
Address
700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8
Website
https://www.sernova.com
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.

Sernova (FRA:PSH) Headlines